KIORA PHARMACEUTICALS, INC. Increase (Decrease) in Contract with Customer, Liability
KIORA PHARMACEUTICALS, INC. (KPRX) reported Increase (Decrease) in Contract with Customer, Liability of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2020-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2020-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2020-06-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2020-03-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for fiscal 2025 was $1.25M.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for fiscal 2024 was $0.00.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for fiscal 2021 was $0.00.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for fiscal 2020 was $0.00.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 | |||
| 2025-12-31 | $1.25M 10-K · filed 2026-03-25 | |||
| 2025-06-30 | $1.25M 10-Q · filed 2026-08-07 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-25 | |||
| 2021-12-31 | $0.00 10-K/A · filed 2022-07-07 | |||
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-07 | $0.00 derived: sum of 2 quarters · filed 2022-07-07 | $0.00 derived: sum of 3 quarters · filed 2022-07-07 | $0.00 10-K/A · filed 2022-07-07 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 4 quarters · filed 2021-03-25 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $0.00 derived: sum of 4 quarters · filed 2021-03-25 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $0.00 derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | -$2.69M 10-K · filed 2021-03-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | -$2.69M 10-Q · filed 2020-11-09 | -$2.69M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$2.69M 10-Q · filed 2020-08-06 | -$2.69M derived: sum of 3 quarters · filed 2020-08-06 | -$2.72M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | -$2.69M 10-Q · filed 2020-05-06 | -$2.69M derived: sum of 2 quarters · filed 2020-05-06 | -$2.72M derived: sum of 3 quarters · filed 2020-05-06 | -$2.05M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | -$37.00K derived: sum of 2 quarters · filed 2020-03-04 | $632.21K derived: sum of 3 quarters · filed 2020-03-04 | $540.21K 10-K · filed 2020-03-04 |
| 2018-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $632.21K derived: sum of 2 quarters · filed 2019-11-07 | $540.21K 10-Q · filed 2019-11-07 | $2.60M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $669.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $577.21K 10-Q · filed 2019-08-08 | $2.64M derived: sum of 3 quarters · filed 2019-08-08 | |
| 2018-03-31 | -$92.00K 10-Q · filed 2019-05-08 | $1.97M derived: sum of 2 quarters · filed 2019-05-08 | ||
| 2017-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $8.09M 10-K · filed 2019-03-01 | ||
| 2017-09-30 | $6.03M 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |